FDA advisers support full approval of Paxlovid for at-risk older adults
By
Alicia Lasek
Mar 16, 2023
The antiviral drug Paxlovid should receive full FDA approval to treat COVID-19 in older adults at risk of severe outcomes, the advisers decided in a Thursday vote.
Alzheimer’s blood biomarkers not ready for primary care use, expert panel decides
By
Alicia Lasek
Aug 18, 2022
An international group of clinicians and researchers have agreed that Alzheimer’s disease blood biomarkers are a significant breakthrough, but are not yet ready for general clinical and primary care...
Educating neurologists, using telehealth improves outcomes in Parkinson’s
By
Kristen Fischer
Nov 14, 2023
A new study looks at palliative care for people living with Parkinson’s disease and related disorders and found that educating neurologists and using telehealth is feasible to improve outcomes for people...
Eli Lilly expects Medicare about-face on Alzheimer’s drugs coverage
By
Alicia Lasek
Apr 23, 2023
New data on Lilly’s experimental drug donanemab may influence CMS’s restrictive stance on coverage of this and other amyloid-busting Alzheimer’s treatments, a company executive says.
VHA to cover new Alzheimer’s drug Leqembi, despite CMS’s restraint
By
Alicia Lasek
Mar 14, 2023
The Veterans Health Administration will provide coverage for the recently approved drug lecanemab (Leqembi) to qualified veterans with early Alzheimer’s disease. It’s a surprise move considering...
AHCA/NCAL to CMS: Safeguard temporary nurse aide jobs by reissuing employment waiver
By
Alicia Lasek
Oct 04, 2022
The industry advocate is urging CMS to reissue a blanket waiver that would allow nursing homes to employ temporary nurse aides beyond the public health emergency.
Study seeks to shed light on COVID-19’s impact on the brain
By
John Roszkowski
Sep 23, 2022
A global consortium of researchers is seeking to uncover the short-term and long-term impacts of COVID-19 on the brain to assess whether it can lead to cognitive impairments later in life such as Alzheimer’s...
Weight loss in early Parkinson’s linked to cognitive decline
Oct 20, 2022
Patients who lose weight within a year of their Parkinson’s diagnosis have a significantly faster decline in Montreal Cognitive Assessment scores, investigators report.
Common diabetes drug may serve as novel Afib treatment
By
Alicia Lasek
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.
CMS: Lapses in infection control, vaccine compliance to garner ‘aggressive’ enforcement
By
Kimberly Marselas
Apr 04, 2023
Federal regulators have quietly put in place new, stricter enforcement measures for nursing homes that struggle to meet infection control and vaccine immunization requirements for residents and staff.